Medical devices, healthcare technology and the business of care
510(k) clearance · K262134

NeuroDR

Deep Reasoning Ai, Inc. · Decision date Oct 7, 2026

MEDTECHLEDGER EXPLANATIONK262134

What did the FDA decide?

FDA recorded a substantially equivalent (SESE) decision for NeuroDR, a 510(k) submitted by Deep Reasoning Ai, Inc. under K262134, with a decision date of October 7, 2026. The device is classified under 21 CFR 892.2050 (medical image management and processing system), product code QIH, in the radiology panel. SESE means the submission was cleared as substantially equivalent; it is not a PMA approval.

NeuroDR is described as a fully automated AI/ML-enabled software device that takes CTA head and neck DICOM data and produces maximum intensity projection, volume rendered, and curved planar reformat outputs returned as DICOM series for physician review. The summary names Rapid Neuro3D (K243350) as the predicate and states the indications and technological characteristics are equivalent. The summary does not provide clinical performance results, and the source does not establish current labeling beyond the documents shown.

Regulatory pathway
510(k) premarket notification
Clinical specialty
Radiology
Decision date
Oct 7, 2026

FDA source record · MedtechLedger’s explanation describes the recorded change.

Regulatory record facts

Identifier
K262134
Regulatory pathway
510(k) premarket notification
Product code
QIH
Decision code
SESE
Decision date
Oct 7, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Automated Radiological Image Processing Software.

Product code
QIH
FDA device class
2

FDA decision timeline

  1. K262134 received

    Application receipt date recorded by FDA.

  2. K262134 · FDA decision

    SESE

Related devices and submissions

Explore the linked device profile

Other records with product code QIH

Product / regulatory recordCompanyPathwayDecision dateSource
Clever OneK260372
Ewoosoft Co., Ltd.510(k) clearanceNov 4, 2026FDA
Peek Health, S.A.510(k) clearanceNov 4, 2026FDA
AVICENNA.AI510(k) clearanceOct 19, 2026FDA
UAB Ligence510(k) clearanceOct 7, 2026FDA
Medis Medical Imaging Systems BV510(k) clearanceOct 5, 2026FDA

A shared product code identifies a classification relationship; it does not establish clinical equivalence.

Regulatory context

A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Deep Reasoning Ai, Inc.

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
Sarasota, FL

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records